FEED

#4995
ENvue Medical, Inc. - Common Stock
0.3 4 USD
-0.08%
Market Price
Settore: Salute
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
0.34
0.34
Intervallo Annuale
0.29
6.09
Variazione giornaliera
-8.11%
Variazione Mensile
+9.68%
Variazione di 6 mesi
-82.65%
Variazione Annuale
-92.64%
Chiusura Precedente
0.3 7
Open
0.3 4
Minimo
0.3 4
Massimo
0.3 4
Volume
2
Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche Documents

2026

Current report, Q3 FY2026
Envue Medical, Inc. current report, Q3 FY2026
8-K
Current report, Q3 FY2026
Envue Medical, Inc. current report, Q3 FY2026
8-K
Current report, Q3 FY2026
Envue Medical, Inc. current report, Q3 FY2026
8-K
Current report, Q3 FY2026
Envue Medical, Inc. current report, Q3 FY2026
8-K
Quarterly report, Q2 FY2026
Envue Medical, Inc. quarterly report, Q2 FY2026
10-Q
Quarterly report, Q1 FY2026
Envue Medical, Inc. quarterly report, Q1 FY2026
10-Q
Current report, Q1 FY2026
Envue Medical, Inc. current report, Q1 FY2026
8-K
Current report, Q1 FY2026
Envue Medical, Inc. current report, Q1 FY2026
8-K

2025

Annual report, FY2025
Envue Medical, Inc. annual report, FY2025
10-K
Current report, Q4 FY2025
Envue Medical, Inc. current report, Q4 FY2025
8-K

Envue Medical, Inc. current report, Q3 FY2026

Full document

Business Context and Reporting Period

Envue Medical, Inc. (Nasdaq: FEED) filed a Current Report on Form 8-K dated July 10, 2026. The filing addresses a regulatory notice regarding the Company's continued listing status on The Nasdaq Capital Market.

Key Financial Metrics

This filing is a notice of delisting risk and does not contain financial statements, revenue, profit, cash flow, or debt metrics. The only financial data point provided is the stock price performance:

  • Stock Price: The closing bid price of the Common Stock was below $1.00 per share for 30 consecutive business days (May 26, 2026, through July 8, 2026).

Material Changes and Delisting Notice

On July 10, 2026, the Company received a Staff Determination Letter from Nasdaq stating it is not in compliance with the Minimum Bid Price Requirement (Nasdaq Listing Rule 5550(a)(2)).

  • Compliance Period: The Company is not eligible for the standard 180-calendar day compliance period.
  • Reason for Ineligibility: The Company effected a 1-for-10 reverse stock split on August 12, 2025, within the prior one-year period, which disqualifies it from the standard cure period under Nasdaq Listing Rule 5810(c)(3)(A)(iv).

Outlook, Management Commentary, and Risks

Management Action: The Company intends to timely request a hearing before the Nasdaq Listing Qualifications Panel to appeal the Staff's determination. A timely request will stay any suspension or delisting action pending the Panel's decision.

Risks and Uncertainties:

  • There is no assurance the Panel will grant the request for continued listing.
  • There is no assurance the Company will be able to regain and maintain compliance with the Minimum Bid Price Requirement.
  • Continued listing may be conditioned on requirements the Company may not be able to satisfy.

Investor Verification Checklist

  • Verify the status of the Company's appeal hearing request with the Nasdaq Listing Qualifications Panel.
  • Monitor the daily closing bid price of FEED stock to assess if it remains below the $1.00 threshold.
  • Review the Company's recent filings (10-K, 10-Q) for underlying financial performance issues contributing to the low stock price.
  • Check for any subsequent 8-K filings regarding the Panel's decision or potential delisting.